home / stock / avhhl / avhhl quote
Last: | $1.49 |
---|---|
Change Percent: | 0.0% |
Open: | $1.49 |
Close: | $1.49 |
High: | $1.49 |
Low: | $1.49 |
Volume: | 285 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.49 | $1.49 | $1.49 | $1.49 | $1.49 | 285 | 07-02-2024 |
$1.62 | $0 | $1.62 | $0 | $0 | 18 | 06-18-2024 |
$1.62 | $1.62 | $1.62 | $1.62 | $1.62 | 105 | 06-13-2024 |
$1.66 | $1.66 | $1.66 | $1.66 | $1.66 | 1,500 | 05-30-2024 |
$1.54 | $1.54 | $1.54 | $1.54 | $1.54 | 100 | 05-21-2024 |
$1.41 | $1.41 | $1.41 | $1.41 | $1.41 | 100 | 05-17-2024 |
$1.77 | $0 | $1.77 | $0 | $0 | 15 | 05-14-2024 |
$1.77 | $1.77 | $1.77 | $1.77 | $1.77 | 250 | 05-06-2024 |
$1.53 | $1.53 | $1.53 | $1.53 | $1.53 | 100 | 04-26-2024 |
$2.1 | $0 | $2.1 | $0 | $0 | 15 | 04-19-2024 |
$2.1 | $0 | $2.1 | $0 | $0 | 55 | 04-16-2024 |
$2.1 | $2.1 | $2.1 | $2.1 | $2.1 | 100 | 04-15-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 100 | 03-29-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 100 | 03-28-2024 |
$3.2 | $3.2 | $3.2 | $3.2 | $3.2 | 600 | 03-25-2024 |
$3.203 | $0 | $3.203 | $0 | $0 | 7 | 03-20-2024 |
$3.203 | $3.203 | $3.203 | $3.203 | $3.203 | 650 | 03-07-2024 |
$2.95 | $2.95 | $2.95 | $2.95 | $2.95 | 666 | 02-23-2024 |
$3.22 | $0 | $3.22 | $0 | $0 | 10 | 02-20-2024 |
$3.22 | $3.22 | $3.22 | $3.22 | $3.22 | 100 | 02-15-2024 |
News, Short Squeeze, Breakout and More Instantly...
VALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the Joseph M. Still Burn Center at Doctors Hosp...
VALENCIA, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has ...
VALENCIA, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the first quarter ended March 31...